Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

npj Breast Cancer (4)
Cell Research (1)
Nature Immunology (1)
npj Precision Oncology (1)
Communications Biology (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (6)
Amendments and Corrections (1)
Research Highlights (1)

Subject Check one or more subjects to show results from those subjects only.

Biological techniques
Biomarkers
Cancer
Immunology
Oncology
Physiology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–8 of 8 results

Advanced filters: Author: Julia Foldi Clear advanced filters

Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer

Luca Licata
Giulia Viale
Giampaolo Bianchini
ResearchOpen Access08 Jun 2023
npj Breast Cancer

Volume: 9, P: 1-7
Notch–RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization

Notch signaling is known to modulate macrophage polarization. Hu and colleagues show that the Notch–RBP-J axis controls the expression of M1 macrophage–specific genes by promoting translation of the transcription factor IRF8.

Haixia Xu
Jimmy Zhu
Xiaoyu Hu
Research20 May 2012
Nature Immunology

Volume: 13, P: 642-650
Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer

Julia Foldi
Andrea Silber
Lajos Pusztai
Amendments and CorrectionsOpen Access03 Feb 2022
npj Breast Cancer

Volume: 8, P: 1
A precision medicine approach to metabolic therapy for breast cancer in mice

Mice with breast cancer driven by mutations upstream of the PI3K/Akt insulin signaling pathway are found to be responsive to dapagliflozin, while those driven by mutations downstream of PI3K/Akt or in pathways with other driver mutations did not.

Ngozi D. Akingbesote
Aaron Norman
Rachel J. Perry
ResearchOpen Access20 May 2022
Communications Biology

Volume: 5, P: 1-11
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers

Tao Qing
Thomas Karn
Lajos Pusztai
ResearchOpen Access07 Nov 2022
npj Breast Cancer

Volume: 8, P: 1-11
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer

Julia Foldi
Andrea Silber
Lajos Pusztai
ResearchOpen Access08 Feb 2021
npj Breast Cancer

Volume: 7, P: 1-7
Immune infiltration correlates with transcriptomic subtypes in primary estrogen receptor positive invasive lobular breast cancer

Fangyuan Chen
Sayali Onkar
Steffi Oesterreich
ResearchOpen Access09 Nov 2024
npj Precision Oncology

Volume: 8, P: 1-8
Precision medicine for metastatic TNBC: the FUTURE is now

Julia Foldi
Charles E. Geyer Jr
Research Highlights08 May 2023
Cell Research

Volume: 33, P: 491-492